explore -WSS

explore

author：fashion 2025-10-02 21:35:23 - browse：447

A pile of medical bills — Medicare coverage from STAT — Medicare will force hospitals to be better about publishing the prices they charge health insurers and patients. Don Petersen/AP

The federal government is moving forward with a spate of proposals that will force hospitals to be better about publishing the prices they charge health insurers and patients.

Federal law has required hospitals to post their prices since 2021. Compliance has been dismal, although it has improved since the government increased fines a few years ago. But the pricing information is still tough to find and confusing to interpret.

The latest regulations, which take effect next year, attempt to streamline reporting. Hospitals already have to publish a machine-readable file listing their prices, but next year, they will have to use a standard template, created by the government, so the information is more uniform and understandable.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Readout LOUD podcast: Live from the 2023 STAT Summit

leisure time

WSS

STAT Summit: How researchers deal with rejection

ADCs take center stage as promising cancer treatments

What Kate Middleton's cancer revelation might teach the world

'Patient friction coefficient' can gauge a clinical trial's patient burden

CZI to create biohub to build anti

Roche acquires Telavant from Roivant, adding experimental IBD treatment

leisure time

explore

Wikipedia

In age of alternative facts, a scholarly course on calling out crap

Chinese researcher claims birth of first gene

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Texas board proposes rules on abortion law emergency exemption

BioMarin wins approval for gene therapy to treat hemophilia A

'Patient friction coefficient' can gauge a clinical trial's patient burden

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

J&J lung cancer data amount to new salvo against AstraZeneca

Alkermes shareholders re

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

leisure time

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Roivant's CEO is a star, but biotech's black hole persists

With Wegovy coverage, Medicare patients may face high costs

'Patient friction coefficient' can gauge a clinical trial's patient burden

U.K. officials, researchers try to ease path for bespoke genetic treatments

Mirador, a new biotech startup, launches with $400 million

hotspot

hotspot

leisure time

focus